149 related articles for article (PubMed ID: 16044964)
1. [Cut-off level of docetaxel, paclitaxel and gemcitabine in histoculture drug response assay for non-small cell lung cancer].
Yoshimasu T; Oura S; Hirai I; Kokawa Y; Hata K; Kawago M; Tanino H; Okamura Y; Furukawa T
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1013-6. PubMed ID: 16044964
[TBL] [Abstract][Full Text] [Related]
2. In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.
Ricotti L; Tesei A; De Paola F; Ulivi P; Frassineti GL; Milandri C; Amadori D; Zoli W
Clin Cancer Res; 2003 Feb; 9(2):900-5. PubMed ID: 12576465
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.
Loprevite M; Favoni RE; de Cupis A; Pirani P; Merlo F; Grossi F; Ardizzoni A
Int J Oncol; 1999 Oct; 15(4):787-92. PubMed ID: 10493963
[TBL] [Abstract][Full Text] [Related]
4. Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC.
Gridelli C; Hainsworth J
Lung Cancer; 2002 Dec; 38 Suppl 4():37-41. PubMed ID: 12480193
[TBL] [Abstract][Full Text] [Related]
5. Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer.
Pimentel FL; Bhalla S; Laranjeira L; Guerreiro M
Lung Cancer; 2006 Jun; 52(3):365-71. PubMed ID: 16650499
[TBL] [Abstract][Full Text] [Related]
6. Data acquisition for the histoculture drug response assay in lung cancer.
Yoshimasu T; Oura S; Hirai I; Tamaki T; Kokawa Y; Hata K; Ohta F; Nakamura R; Kawago M; Tanino H; Okamura Y; Furukawa T
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):303-8. PubMed ID: 17258552
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02).
Hosoe S; Komuta K; Shibata K; Harada H; Iwamoto Y; Ohsaki Y; Morioka T; Origasa H; Fukushima M; Furuse K; Kawahara M
Br J Cancer; 2003 Feb; 88(3):342-7. PubMed ID: 12569374
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy resistance and oncogene expression in non-small cell lung cancer.
d'Amato TA; Landreneau RJ; Ricketts W; Huang W; Parker R; Mechetner E; Yu IR; Luketich JD
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):352-63. PubMed ID: 17258563
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer.
Zoli W; Ricotti L; Dal Susino M; Barzanti F; Frassineti GL; Folli S; Tesei A; Bacci F; Amadori D
Br J Cancer; 1999 Oct; 81(4):609-15. PubMed ID: 10574245
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer.
Yoshimasu T; Oura S; Ohta F; Hirai Y; Naito K; Nakamura R; Nishiguchi H; Hashimoto S; Kawago M; Okamura Y
J Thorac Oncol; 2011 Oct; 6(10):1658-62. PubMed ID: 21681119
[TBL] [Abstract][Full Text] [Related]
13. [Dose response curve of paclitaxel measured by histoculture drug response assay].
Yoshimasu T; Oura S; Hirai I; Kokawa Y; Okamura Y; Furukawa T
Gan To Kagaku Ryoho; 2005 Apr; 32(4):497-500. PubMed ID: 15853216
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer.
Rodgers M; Soares M; Epstein D; Yang H; Fox D; Eastwood A
Health Technol Assess; 2011 May; 15 Suppl 1():1-12. PubMed ID: 21609648
[TBL] [Abstract][Full Text] [Related]
15. [A case of docetaxel-resistant lung cancer effectively treated with chemotherapy of gemcitabine and vinorelbine].
Daido K; Arita K; Ohashi N; Nakamura K
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1747-50. PubMed ID: 11057328
[TBL] [Abstract][Full Text] [Related]
16. Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study.
Ibrahim T; Zoli W; Frassineti GL; Tesei A; Colantonio I; Monti M; Amadori D
Lung Cancer; 2005 Feb; 47(2):261-7. PubMed ID: 15639725
[TBL] [Abstract][Full Text] [Related]
17. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
18. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
[TBL] [Abstract][Full Text] [Related]
19. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.
Kubota K; Kawahara M; Ogawara M; Nishiwaki Y; Komuta K; Minato K; Fujita Y; Teramukai S; Fukushima M; Furuse K;
Lancet Oncol; 2008 Dec; 9(12):1135-42. PubMed ID: 19013107
[TBL] [Abstract][Full Text] [Related]
20. [Phase I study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non-small-cell lung cancer].
Terao I
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1929-33. PubMed ID: 12465392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
